One clue about this that appears to have slipped past quite a few people, is some work by the WPI with a treatment study. I can't remember where I saw this, or what the treatment was, but I have a feeling it was Ampligen. I'm also not sure what the nature of that paper was, but it wasn't published, obviously. Maybe a conference presentation / poster.
Anyway: the finding was that the patients who were negative for antibodies were less responsive to the treatment.
It was a worrying finding, I'm afraid, for patients who are negative for antibodies. The implication to me seemed to be that there is variation
amongst patients as to their ability to mount an effective immune response to XMRV, and that those who are unable to mount an effective immune response are less likely to benefit from the treatment. The paper also prompted me to wonder whether this difference might also represent the difference between the "frequent colds" and "never catch colds" versions of ME, or the difference between 'severe' and 'moderate' symptoms. Hate to be the bearer of bad news here: it's all very preliminary of course, but that's all we have to go on at the moment. Hopefully somebody will remember the paper I'm referring to...
Regarding setting up a poll: it's quite easy to do as an option when creating a new thread. The most common errors are failing to make the view of who voted for what private (there's an option on the 'create poll' for that) and failing to think through the options in the poll. I suggest that people on this thread draft out a question and a list of options, refine it together a bit, and then create the poll. No great expertise required.